Helping Life Sciences Organizations Reach More Patients

International Marketing Solutions for the Life Sciences Industry

Get a Free Consult
Dark purple lab drip

Targeted Patient Campaigns for Anywhere in the World, in Any Language

  1. Roughly 80% of clinical trials fail to meet enrollment timelines.
  2. Approximately one-third (30%) of Phase III study terminations are due to enrollment difficulties.
  3. As these statistics make abundantly clear, better patient recruitment processes can drastically improve clinical trial success.

Create Strategic Global Patient Recruitment Campaigns

We can help with our extensive market research, global expertise, and local digital marketing experts

  • Market Insights – Mapping the Patient Journey
  • Cultural Consulting – Adapting Content for Intended Audiences
  • Regulatory Consulting – Advising on Local Regulations (e.g., Promotional Liability in the EU)
  • Medical Writing & Content Development
  • Digital Strategy
  • Translation and Media
  • Technology to Streamline Approval Process

Benefits of TransPerfect's Digital Patient Engagement Solutions

Patient recruitment consumes 27% of the cost of development–that is $5.9 billion annually around the world.

  • Icon Timelines

Shrink Timelines for Creating and Launching Campaigns

  • Icon Save Money

Save Money on Campaign Planning and Execution

  • Icon Marketing

Retain More Patients with Improved Targeting and Patient Education

  • Icon Regulatory

Maintain Protocol Adherence and Reduce Compliance Risks

Streamline Patient Recruitment Strategies

A diverse and inclusive patient recruitment strategy is key to ensuring a successful clinical trial. TransPerfect Life Sciences supports pharmaceutical companies in reaching patients, meeting enrollment numbers, and meeting diversity and inclusion goals. With extensive market research and global expertise, our local digital marketing experts develop strategic recruitment marketing plans and messaging that engage patients across all channels.

Trusted by Life Sciences Organizations Big and Small

Join TransPerfect's community of over 1,000 life sciences organizations, including pharma, biotech, CROs, IRBs, and agencies.

20230124-lifesciences-resize-v3_0022_400x160px-hologic_logo.png
untitled_design_4.png
20230124-lifesciences-resize-v3_0016_400x160px-bayer_logo.png
20230124-lifesciences-resize-v3_0015_400x160px-merck_logo.png

Ready to Reach More Patients?

Schedule a free consult.

How did you hear about us?
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

News and Thought Leadership

Our industry experts have in-depth understanding of the challenges, requirements, and goals for life sciences organizations.

eConsent: Why the Content Matters as Much as the Tech

Insights from a conversation with Edwin Cohen, Principal Consultant / Owner at C&Flow Instrument Creation and Mark P Wade Global Practice Leader & COA SME, TransPerfect Life Sciences For all the attention paid to the systems, platforms, and integrations behind electronic informed consent (eConsent), the real barrier to adoption may not be technical at all. It may be the words on the page. That's the central argument from Edwin Cohen, whose research has ...

eConsent: Why the Content Matters as Much as the Tech

LifeSci Talks COA Series | The "Frankenstein Instrument" Problem: Why Some PRO Measures Don't Fit Today's Patients

Are the COA Instruments we've relied on for decades still measuring what matters to patients today? In this episode, Mark Wade sits down with Kathrin Fischer PhD, Patient-Centered Outcome Strategy Lead at Boehringer Ingelheim and ISOQOL Director-at-Large Term: 2024 – 2027, ...

Has eCOA Lived up to Its Promise? A Retrospective View on the Evolution of Electronic Clinical Outcome Assessments

The Evolution of eCOA: Progress, Challenges, and the Road AheadElectronic clinical outcome assessments (eCOAs) were expected to make paper obsolete by improving data quality, reducing missing data, and enabling decentralized clinical trials.More than two decades later, that...

How a Leading eCOA Provider Cut Timelines by 60% with GlobalLink Strings Integration

Discover how a leading eCOA provider slashed project timelines by 30% and screenshot review cycles by more than 60% by integrating GlobalLink Strings into its platform. This case study breaks down the roadmap, the rollout, and the efficiency gains that followed. See how ...

Breaking Down Silos: The Key to Effective Collaboration and Safety Signal Management

Insights from an XTalks webinar on collaboration between Medical Information, Pharmacovigilance, and Regulatory AffairsIn pharmaceutical organizations, critical safety information is often received by multiple teams. Medical Information (MI) receives inquiries from healthcare...

The 5-Step AI Readiness Checklist for Medical Device Manufacturers

Only one in four manufacturers using process AI say it's meeting expectations. The gap between those results and the rest comes down to preparation. This checklist is built from patterns shared by manufacturers that are seeing results, along with the gaps most commonly found ...

LifeSci Talks COA Series | eConsent: Why the Content Matters as Much as the Tech

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Edwin Cohen, Principal Consultant at C&Flow, to talk about eConsent adoption in clinical trials. They discuss the research behind why animated, electronic consent ...